Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021

SELL
$56.61 - $80.46 $914,025 - $1.3 Million
-16,146 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$86.23 - $125.19 $198,587 - $288,312
-2,303 Reduced 12.48%
16,146 $1.5 Million
Q4 2020

Feb 04, 2021

SELL
$79.17 - $111.47 $6,491 - $9,140
-82 Reduced 0.44%
18,449 $1.65 Million
Q3 2020

Oct 23, 2020

SELL
$81.91 - $134.94 $6.32 Million - $10.4 Million
-77,203 Reduced 80.64%
18,531 $1.92 Million
Q2 2020

Aug 03, 2020

BUY
$54.33 - $89.52 $3.64 Million - $6 Million
67,025 Added 233.46%
95,734 $7.57 Million
Q1 2020

May 08, 2020

SELL
$49.34 - $68.76 $994,793 - $1.39 Million
-20,162 Reduced 41.26%
28,709 $1.66 Million
Q4 2019

Feb 10, 2020

SELL
$51.21 - $59.06 $59,557 - $68,686
-1,163 Reduced 2.32%
48,871 $2.64 Million
Q3 2019

Oct 23, 2019

SELL
$40.6 - $57.2 $19,853 - $27,970
-489 Reduced 0.97%
50,034 $2.62 Million
Q2 2019

Jul 18, 2019

SELL
$39.92 - $53.86 $6,027 - $8,132
-151 Reduced 0.3%
50,523 $2.44 Million
Q1 2019

Apr 22, 2019

SELL
$48.23 - $66.16 $131,282 - $180,087
-2,722 Reduced 5.1%
50,674 $2.56 Million
Q4 2018

Jan 10, 2019

SELL
$55.63 - $73.24 $21,528 - $28,343
-387 Reduced 0.72%
53,396 $3.52 Million
Q4 2018

Jan 10, 2019

BUY
$55.63 - $73.24 $21,528 - $28,343
387 Added 0.72%
53,783 $3.19 Million
Q3 2018

Oct 17, 2018

SELL
$52.05 - $66.51 $4,216 - $5,387
-81 Reduced 0.15%
53,396 $3.52 Million
Q2 2018

Jul 19, 2018

SELL
$48.33 - $55.64 $158,667 - $182,666
-3,283 Reduced 5.78%
53,477 $2.7 Million
Q1 2018

May 16, 2018

SELL
$44.44 - $54.39 $11,821 - $14,467
-266 Reduced 0.47%
56,760 $2.99 Million
Q4 2017

Jan 25, 2018

SELL
$37.77 - $47.75 $1.68 Million - $2.12 Million
-44,496 Reduced 43.83%
57,026 $2.65 Million
Q3 2017

Oct 31, 2017

BUY
$34.14 - $40.45 $3.47 Million - $4.11 Million
101,522
101,522 $4.11 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.